Propofol Protects the Immature Rabbit Heart against Ischemia and Reperfusion Injury: Impact on Functional Recovery and Histopathological Changes

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Shirakawa, Makoto ^a   Imura, Hajime ^b   Nitta, Takashi ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NIPPON MEDICAL SCHOOL MUSASHI KOSUGI HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; LACTIC ACID; PROPOFOL; CYCLOSPORIN; PROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ULTRASTRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY BLOOD FLOW; DRUG EFFICACY; ELECTRON MICROSCOPY; HEART ATRIUM APPENDAGE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PERFUSION; HEART PROTECTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMIC PARAMETERS; HISTOPATHOLOGY; MICROSCOPY; NONHUMAN; REPERFUSION INJURY; ANIMAL; DRUG EFFECTS; HEART; HEMODYNAMICS; METABOLISM; PATHOLOGY; RABBIT;

ORYCTOLAGUS CUNICULUS;

ANIMALS; CYCLOSPORINE; HEART; HEMODYNAMICS; LACTIC ACID; MYOCARDIUM; PROPOFOL; PROTECTIVE AGENTS; RABBITS; REPERFUSION INJURY;

EID: 84923043233     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/601250     Document Type: Article

References (44)

1. A. P. Halestrap, S. J. Clarke, and S. A. Javadov, "Mitochondrial permeability transition pore opening during myocardial reperfusion-A target for cardioprotection, " Cardiovascular Research, vol. 61, no. 3, pp. 372-385, 2004.
2. A. P. Halestrap, "Calcium, mitochondria and reperfusion injury: a pore way to die, " Biochemical Society Transactions, vol. 34, no. 2, pp. 232-237, 2006.
3. M. Suleiman, A. P. Halestrap, and E. J. Griffiths, "Mitochondria: a target for myocardial protection, " Pharmacology and Therapeutics, vol. 89, no. 1, pp. 29-46, 2001.
4. S. J. Clarke, G. P. McStay, and A. P. Halestrap, "Sanglifehrin A acts as a potent inhibitor of the mitochondrial permeability transition and reperfusion injury of the heart by binding to cyclophilin-D at a different site fromcyclosporinA, "TheJournal of Biological Chemistry, vol. 277, no. 38, pp. 34793-34799, 2002.
5. J.-R. Xie and L.-N. Yu, "Cardioprotective effects of cyclosporine A in an in vivo model of myocardial ischemia and reperfusion, " Acta Anaesthesiologica Scand inavica, vol. 51, no. 7, pp. 909-913, 2007.
6. J. G. Bovill, "Intravenous anesthesia for the patientwithleftventricular dysfunction, " Seminars in Cardiothoracic and Vascular Anesthesia, vol. 10, no. 1, pp. 43-48, 2006.
7. H. M. Bryson, B. R. Fulton, and D. Faulds, "Propof ol: an update of its use in anaesthesia and conscious sedation, " Drugs, vol. 50, no. 3, pp. 513-559, 1995.
8. R. Kato and P. Foex, "Myocardial protection by anesthetic agents against ischemia-reperfusion injury: an update for anesthesiologists, " Canadian Journal of Anesthesia, vol. 49, no. 8, pp. 777-791, 2002.
9. N. Kokita, A. Hara, Y. Abiko, J. Arakawa, H. Hashizume, and A. Namiki, "Propof ol improves functional and metabolic recovery in ischemic reperfused isolated rat hearts, " Anesthesia & Analgesia, vol. 86, no. 2, pp. 252-258, 1998.
10. N. Kokita and A. Hara, "Propof ol attenuates hydrogen peroxideinduced mechanical and metabolic derangements in the isolated rat heart, " Anesthesiology, vol. 84, no. 1, pp. 117-127, 1996.
11. S. A. Javadov, K. H. H. Lim, P. M. Kerr, M. Suleiman, G. D. Angelini, and A. P. Halestrap, "Protection of hearts from reperfusion injury by propof ol is associated with inhibition of the mitochondrial permeability transition, " Cardiovascular Research, vol. 45, no. 2, pp. 360-369, 2000.
12. N. King, M. Al Shaama, and M. S. Suleiman, "Propof ol improves recovery of the isolated working hypertrophic heart from ischaemia-reperfusion, " Pflugers Archiv European Journal of Physiology, vol. 464, no. 5, pp. 513-522, 2012.
13. N. Stratford and P. Murphy, "Antioxidant activity of propof ol in blood from anaesthetized patients, " European Journal of Anaesthesiology, vol. 15, no. 2, pp. 158-160, 1998.
14. Z. Xia, D. V. Godin, and D. M. Ansley, "Propof ol enhances ischemic tolerance of middle-aged rat hearts: Effects on 15-F2t-isoprostane formation and tissue antioxidant capacity, " Cardiovascular Research, vol. 59, no. 1, pp. 113-121, 2003.
15. Z. Xia, D. V. Godin, T. K. H. Chang, and D. M. Ansley, "Dosedependent protection of cardiac function by propof ol during ischemia and early reperfusion in rats: effects on 15-F2β-isoprostane formation, " Canadian Journal of Physiology and Pharmacology, vol. 81, no. 1, pp. 14-21, 2003.
16. N. Buljubasic, J. Marijic, V. Berczi, D. F. Supan, J. P. Kampine, and Z. J. Bosnjak, "Differential effects of etomidate, propof ol, and midazolam on calcium and potassium channel currents in caninemyocardial cells, " Anesthesiology, vol. 85, no. 5, pp. 1092-1099, 1996.
17. Y. C. Li, P. Ridefelt, L. Wiklund, and G. Bjerneroth, "Propof ol induces a lowering of free cytosolic calciuminmyocardial cells, " Acta Anaesthesiologica Scand inavica, vol. 41, no. 5, pp. 633-638, 1997.
18. N. Roy, I. Friehs, D. B. Cowan, D. Zurakowski, F. X. McGowan, and P. J. del Nido, "Dopamine induces postischemic cardiomyocyte apoptosis in vivo: an effect ameliorated by propof ol, " The Annals of Thoracic Surgery, vol. 82, no. 6, pp. 2192-2199, 2006.
19. K. H. H. Lim, A. P. Halestrap, G. D. Angelini, and M. Suleiman, "Propof ol is cardioprotective in a clinically relevant model of normothermic blood cardioplegic arrest and cardiopulmonary bypass, " Experimental Biology and Medicine, vol. 230, no. 6, pp. 413-420, 2005.
20. B. Ostadal, I. Ostadalova, and N. S. Dhalla, "Development of cardiac sensitivity to oxygen deficiency: comparative and ontogenetic aspects, " Physiological Reviews, vol. 79, no. 3, pp. 635-659, 1999.
21. E. Riva and D. J. Hearse, The Developing Myocardium, Futura, Mount Kisco, NY, USA, 1991.
22. K. G. Warner, M. G. Sheahan, S. M. Arebi, A. Banerjee, J. M. Deiss-Shrem, and K. R. Khabbaz, "Proper timing of blood cardioplegia in infant lambs: superiority of a multiple-dose regimen, " Annals of Thoracic Surgery, vol. 71, no. 3, pp. 872-876, 2001.
23. N. Oka, L. Wang, W. Mi, W. Zhu, O. Honjo, and C. A. Caldarone, "Cyclosporine A prevents apoptosis-related mitochondrial dysfunction after neonatal cardioplegic arrest, " Journal of Thoracic and Cardiovascular Surgery, vol. 135, no. 1, pp. 123-e2, 2008.
24. M. Milerova, Z. Charvatova, L. Skarka, et al., "Neonatal cardiac mitochondria and ischemia/reperfusion injury, " Molecular and Cellular Biochemistry, vol. 335, no. 1-2, pp. 147-153, 2010.
25. J. E. Baker, B. D. Curry, G. N. Olinger, and G. J. Gross, "Increased tolerance of the chronically hypoxic immature heart to ischemia. Contribution of the K(ATP) channel, " Circulation, vol. 95, no. 5, pp. 1278-1285, 1997.
26. H. Imura and M. S. Suleiman, "Cardioprotection of neonatal heart using normothermic hyperkalaemia: the importance of delivery and terminal cardioplegia, " Molecular and Cellular Biochemistry, vol. 310, no. 1-2, pp. 1-9, 2008.
27. H. Fujiwara, M. Ashraf, S. Sato, and R. W. Millard, "Transmural cellular damage and blood flow distribution in early ischemia in pig hearts, " Circulation Research, vol. 51, no. 6, pp. 683-693, 1982.
28. P. Olivier, D. Sirieix, P. Dassier, N. DAttellis, and J. Baron, "Continuous infusion of remifentanil and target-controlled infusion of propof ol for patients undergoing cardiac surgery: a new approach for scheduled early extubation, " Journal of Cardiothoracic and Vascular Anesthesia, vol. 14, no. 1, pp. 29-35, 2000.
29. S. Zhang and S. Yao, "Potent antioxidative potential of propof ol during cardiopulmonary bypass in the adult, " Journal of Tongji Medical University, vol. 21, no. 4, pp. 349-352, 2001.
30. W. F. Xia, Y. Liu, Q. S. Zhou, Q. Tang, and H. Zou, "Protective effect of propof ol and its relation to postoperation recovery in children undergoing cardiac surgery with cardiopulmonary bypass., " Pediatric cardiology, vol. 32, no. 7, pp. 940-946, 2011.
31. W. F. Xia, Y. Liu, Q. S. Zhou, Q. Tang, and H. Zou, "Comparison of the effects of propof ol and midazolam on inflammation and oxidase stress in children with congenital heart disease undergoing cardiac surgery, " Yonsei Medical Journal, vol. 52, no. 2, pp. 326-332, 2011.
32. I. Constant and A. Rigouzzo, "Which model for propof ol TCI in children, " Paediatric Anaesthesia, vol. 20, no. 3, pp. 233-239, 2010.
33. C. Yang, C. Wong, C. Yu, H. Luk, and C. Lin, "Propof ol inhibits cardiac L-type calcium current in guinea pig ventricular myocytes, " Anesthesiology, vol. 84, no. 3, pp. 626-635, 1996.
34. D. J. Cook and P. R. Housmans, "Mechanism of the negative inotropic effect of propof ol in isolated ferret ventricular myocardium, " Anesthesiology, vol. 80, no. 4, pp. 859-871, 1994.
35. F. Sztark, F. Ichas, R. Ouhabi, P. Dabadie, and J. Mazat, "Effects of the anaesthetic propof ol on the calcium-induced permeability transition of rat heart mitochondria: direct pore inhibition and shift of the gating potential, " FEBS Letters, vol. 368, no. 1, pp. 101-104, 1995.
36. N. Kamada, N. Kanaya, N. Hirata, S. Kimura, and A. Namiki, "Cardioprotective effects of propof ol in isolated ischemiareperfused guinea pig hearts: role of KATP channels and GSK-3β, " Canadian Journal of Anesthesia, vol. 55, no. 9, pp. 595-605, 2008.
37. T. B. Corcoran, A. Engel, H. Sakamoto, A. OShea, S. OCallaghan-Enright, and G. D. Shorten, "The effects of propof ol on neutrophil function, lipid peroxidation and inflammatory response during elective coronary artery bypass grafting in patients with impaired ventricular function, " British Journal of Anaesthesia, vol. 97, no. 6, pp. 825-831, 2006.
38. M. Ashraf, F. White, and C. M. Bloor, "Ultrastructural influences of reperfusing dog myocardium with calcium-free blood after coronary artery occlusion, " The American Journal of Pathology, vol. 90, no. 2, pp. 423-434, 1978.
39. H. Imura, B. E. Ayres, and M.-S. Suleiman, "Purine metabolism and release during cardioprotection with hyperkalemia and hypothermia, "Molecular and Cellular Biochemistry, vol. 237, no. 1-2, pp. 119-127, 2002.
40. R. A. Kloner, M. C. Fishbein, E. Braunwald, and P. R. Maroko, "Effect of propranolol on mitochondrial morphology during acute myocardial ischemia, " The American Journal of Cardiology, vol. 41, no. 5, pp. 880-886, 1978.
41. W. K. Park and C. Lynch III, "Propof ol and thiopental depressin of mycocardial contractility. Acomparative study of mechanical and electrophysiologic effects in isolated guinea pig ventricular muscle, " Anesthesia and Analgesia, vol. 74, no. 3, pp. 395-405, 1992.
42. D. Branca, E. Vincenti, and G. Scutari, "Influence of the anesthetic 2, 6-diisopropylphenol (propof ol) on isolated rat heart mitochondria, " Comparative Biochemistry and Physiology C, vol. 110, no. 1, pp. 41-45, 1995.
43. M. Riqoulet, A. Devin, N. Averet, B. Vandais, and B. Guerin, "Mechanisms of inhibition and uncoupling of resporation in isolated rat liver mitochondria by the general anesthetic 2, 6-diidopropylphenol, " European Journal of Biochemistry, vol. 241, no. 1, pp. 280-285, 1996.
44. N. J. Solenski, C. G. DiPierro, P. A. Trimmer, A. Kwan, and G. A. Helms, "Ultrastructural changes of neuronalmitochondria after transient and permanent cerebral ischemia, " Stroke, vol. 33, no. 3, pp. 816-824, 2002.